株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の主要医薬品企業におけるゲームチェンジ戦略

Game-changing Strategies of Leading US Pharma Companies

発行 Frost & Sullivan 商品コード 487845
出版日 ページ情報 英文 68 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.71円で換算しております。
Back to Top
米国の主要医薬品企業におけるゲームチェンジ戦略 Game-changing Strategies of Leading US Pharma Companies
出版日: 2017年03月14日 ページ情報: 英文 68 Pages
概要

当レポートでは、米国の医薬品産業における薬物研究、製造、サプライチェーン、およびマーケティング関連の変化にフォーカスして調査しており、主要企業が重点を置く主な治療領域、

エグゼクティブサマリー

米国の医薬品企業におけるエコシステム

米国の医薬品企業における革新の5大テーマ

米国の医薬品企業トップ10

戦略的成長手段1:中核領域へのフォーカス

戦略的成長手段2:デジタルフットプリント

戦略的成長手段3:バリューチェーンの素晴らしさ

戦略的成長手段4:戦略コラボレーション/アライアンスまたは提携

戦略的成長手段5:ピル以外のサービス・ソリューション

企業プロファイル:Pfizer

企業プロファイル:Gilead

企業プロファイル:Johnson & Johnson

企業プロファイル:Merck & Co.

企業プロファイル:Amgen

総論

Frost & Sullivan について

目次
Product Code: 9AB9/6D

Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth

The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes across drug development and manufacturing as well as supply chain and logistics. It also analyzes the dynamics catalyzing growth, profiles organizations promising significant growth opportunities, and outlines innovative industry trends of key participants who play a vital role in the pharmaceutical landscape. Furthermore, the research also highlights the adoption of newer business models by the game-changing companies to adapt to the changing trend of a value-based care model as opposed to the traditional volume-based model.

Key Target Audience:

  • Small to mid-sized pharma and biotech companies which need to benchmark their capabilities with respect to the game-changing companies
  • Big pharma companies interested in gaining an understanding of the competitive landscape with respect to strategic growth levers

Research Scope:

The research service covers the top 5 pharmaceutical companies in the United States (US), based on their industry position. The companies included in the study are Pfizer, Gilead, Johnson & Johnson, Merck & Co., and Amgen. These companies are benchmarked across 5 key growth levers:

  • Core areas of focus
  • Digital footprint
  • Value chain excellence
  • Strategic collaborations and partnerships, and
  • Beyond the pill services and solutions

The benchmarking across these strategic growth levers would provide insights into their positioning with respect to the changing market landscape as well as measures taken by these companies to align themselves with these changing market needs. Furthermore, there are additional highlights provided on the companies being profiled.

Highlights of the company profiles include:

  • Company snapshot
  • Performance analysis (market revenue forecast)
  • Portfolio analysis
  • Key marketed products and patent expiry
  • SWOT analysis
  • Strategic analysis of growth levers

Key Questions this Study will Answer:

  • What are the key therapeutic focus areas for the leading pharmaceutical companies in the US?
  • What are the major growth levers affecting the growth trajectory of pharma companies in the US?
  • In what ways are these growth levers impacting the company profitability?
  • Which are the major game-changing companies in the US?
  • What are the strategies adopted by these companies to meet the changing market needs?
  • How are the companies performing across these strategic growth levers?

Table of Contents

1. GAME-CHANGING STRATEGIES OF LEADING US PHARMA COMPANIES

Executive Summary

  • Executive Summary
  • Key Questions this Study will Answer

US Pharma Ecosystem

  • US Pharma Ecosystem

5 Big Themes for Innovation in US Pharma Companies

  • 5 Big Themes for Innovation in US Pharma Companies

Top 10 US Pharma Companies

  • Top 10 US Pharma Companies

Strategic Growth Lever 1-Focus on Core Areas

  • Focus on Core Areas

Strategic Growth Lever 2-Digital Footprint

  • Digital Footprint

Strategic Growth Lever 3-Value Chain Excellence

  • Value Chain Excellence

Strategic Growth Lever 4-Strategic Collaborations/ Alliances or Partnerships

  • Strategic Collaborations/Alliances or Partnerships

Strategic Growth Lever 5-Beyond the Pill Services and Solutions

  • Beyond the Pill Services and Solutions

Company Profile-Pfizer

  • Pfizer Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Patent Expiry
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers

Company Profile-Gilead

  • Gilead Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Product Expiry
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers

Company Profile-Johnson & Johnson

  • JNJ Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Patent Expiry
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers

Company Profile-Merck & Co.

  • Merck Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Patent Expiry
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers

Company Profile-Amgen

  • Amgen Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Patent Expiry
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers

The Last Word

  • The Last Word
  • Legal Disclaimer

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top